Healthcare Professionals
Consulta CRT-P
Cardiac Resynchronization Therapy Pacemaker
Consulta Cardiac Resynchronization Pacemaker (CRT-P)
The Medtronic Consulta® CRT-P system is designed specifically for patients who are candidates for cardiac resynchronization therapy and indicated for a bradycardia pacemaker.
How It Works
Consulta® CRT-P combines industry-leading pacing technology, cardiac resynchronization therapy, and Medtronic exclusive features for proactive heart failure management.
- Exclusive OptiVol Fluid Status Monitoring
- Five pacing vectors
- Ensure CRT with exclusive Complete Capture Management
- Convenient follow-up with leadless ECG and Medtronic CareLink® Network
Important Safety Information
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features and may impact longevity.
| Medtronic Exclusives | |||||
|---|---|---|---|---|---|
| Exclusive | Exclusive | Exclusive | |||
| OptiVol Monitoring |
5 Pacing Vectors |
Complete Capture Management |
Leadless ECG |
CareLink Network |
|
| Consulta® CRT-P Pacemaker |
x | x | x | x | x |
Diagnostics
Heart Failure Diagnostics
Medtronic heart failure diagnostic tools help clinicians identify patients at risk of heart failure hospitalization:1-7
OptiVol® Fluid Status Monitoring uses intrathoracic impedance to indicate fluid status in heart failure patients.
CardioSight Reader helps clinicians quickly identify issues and respond to significant clinical events in heart failure patients.
Important Safety Information
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features and may impact longevity.
References
1
Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. August 9, 2005; 112(6):841-848.
2
Vollmann D, Nägele H, Schauert P, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. August 2007; 28(15):1835-1840.
3
Catanzariti D, Lunati M, Landolina M, et al. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. PACE. March 2008; 32(3):363-370.
4
Perego GB, Landolina M, Vergara G, et al. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. J Interv Card Electrophysiol. December 2008; 23(3):235-242.
5
Small RS, Wickemeyer W, Germany R, et al. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. August 2009;15(6):475-481.
6
Abraham WT. Superior performance of intrathoracic impedance-derived fluid index versus daily weight monitoring in heart failure patients. Results of the Fluid Accumulation Status Trial. Late Breaking Clinical Trials. J Card Fail. Vol. 15 No. 9 2009, p 813.
7
Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients with Heart Failure) study. J Am Coll Cardiol. April 27, 2010;55(17):1803-1810.
